RBC Capital analyst TJ Schultz upgrades Sitio Royalties (NYSE:STR) from Sector Perform to Outperform and raises the price target from $36 to $43.
Citigroup Maintains Buy on Longboard Pharmaceuticals, Lowers Price Target to $17
Citigroup analyst Neena Bitritto-Garg maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and lowers the price target from $24 to $17.